Sunil Agarwal, MD, from Mount Sinai Hospital in New York, discussed the results of his research on the use of continuous cardiac monitoring to monitor elderly patients for atrial fibrillation and sub-clinical arrhythmia and help reduce their risk of stroke and other health complications.
AstraZeneca researchers report that a new drug call MED12452 is being developed as an antidote for patients who need to reverse the effects of ticagrelor (Brilinta/AstraZeneca) on an emergency basis. That could be important for patients taking ticagrelor who need emergency surgery or are bleeding from an accident.
There is a higher risk of certain types of cancer in patients who survive myocardial infarction, according to researchers in Copenhagen, Denmark.
Study results presented at ACC.14 show treatment with PCSK9 inhibitor evolocumab significantly reduces LDL-cholesterol levels in patients with hypercholesterolemia.
News and updates about ACC.13, the 2013 Scientific Session of the American College of Cardiology.
A novel mitral valve clip was proven to be as safe and effective as open-chest surgery in selected patients with mitral valve regurgitation.